Zhang X, Zhu HY, Yuan M. Efficacy and safety of B-ultrasound-guided radiofrequency ablation in the treatment of primary liver cancer: Systematic review and meta-analysis. World J Gastrointest Surg 2024; 16(9): 2986-2995 [PMID: 39351568 DOI: 10.4240/wjgs.v16.i9.2986]
Corresponding Author of This Article
Xiong Zhang, MM, Department of Nursing, Guizhou Nursing Vocational College, No. 338 Dazhi Road, Huaxi District, Guiyang 550025, Guizhou Province, China. zhangxiong_199608@163.com
Research Domain of This Article
Dentistry, Oral Surgery & Medicine
Article-Type of This Article
Meta-Analysis
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2986-2995 Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2986
Efficacy and safety of B-ultrasound-guided radiofrequency ablation in the treatment of primary liver cancer: Systematic review and meta-analysis
Xiong Zhang, Hong-Yi Zhu, Ming Yuan
Xiong Zhang, Hong-Yi Zhu, Department of Nursing, Guizhou Nursing Vocational College, Guiyang 550025, Guizhou Province, China
Ming Yuan, Department of Hepatobiliary Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China
Author contributions: Zhang X wrote the manuscript; Zhu HY collected the data; Yuan M guided the study; all authors reviewed, edited, and approved the final manuscript and revised it critically for important intellectual content, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work.
Conflict-of-interest statement: The authors declare no conflicts of interest.
PRISMA 2009 Checklist statement: This study strictly followed PRISMA 2009 inventory guidelines to ensure transparency and reproducibility of the systematic review and meta-analysis process. We follow PRISMA standards in literature screening, data extraction and analysis to improve the quality and credibility of research and provide readers with clear and comprehensive findings and conclusions.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiong Zhang, MM, Department of Nursing, Guizhou Nursing Vocational College, No. 338 Dazhi Road, Huaxi District, Guiyang 550025, Guizhou Province, China. zhangxiong_199608@163.com
Received: May 7, 2024 Revised: July 30, 2024 Accepted: August 1, 2024 Published online: September 27, 2024 Processing time: 133 Days and 23.5 Hours
Core Tip
Core Tip: To evaluate the efficacy and safety of B-ultrasound-guided radiofrequency ablation (RFA) in the treatment of primary liver cancer by meta-analysis. This study systematically searched a variety of medical databases, screened out clinical trials and observational studies that met the criteria, extracted relevant data, and used statistical methods for comprehensive analysis. The key indicators of RFA, such as tumor ablation success rate, patient survival rate, complication rate and postoperative recurrence rate, were mainly concerned. Through comparison and analysis, the aim is to provide more powerful evidence support for clinical practice, optimize the treatment strategy of primary liver cancer, and improve the quality of life and prognostic effect of patients.
